Clinical trials
Observational Acute Coronary Syndrome trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2010 | 6 |
| 2011 | 5 |
| 2013 | 4 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Unknown status | 7 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 7 |
| University Hospital, Strasbourg, France | 5 |
| French Cardiology Society | 4 |
| AstraZeneca | 3 |
| Centre Hospitalier Universitaire de Saint Etienne | 2 |
| Saint Antoine University Hospital | 2 |
| University Hospital, Montpellier | 2 |
| University Hospital, Toulouse | 2 |
| Action, France | 1 |
| Biotronik France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Coronary Syndrome | 43 |
| Myocardial Infarction | 12 |
| Angina, Unstable | 4 |
| Chest Pain | 4 |
| Arrhythmias, Cardiac | 3 |
| Coronary Artery Disease | 3 |
| Heart Diseases | 2 |
| Acute Kidney Injury | 1 |
| Angina, Stable | 1 |
| Atherosclerosis | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.